UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 71.80
0.00 (0.00%)
Sep 30, 2026, 1:30 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 4.57 billion as of September 29, 2026. Its market cap has decreased by -12.03% in one year.
Market Cap
4.57B
Enterprise Value
3.92B
Revenue
22.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
71.80
ChartMarket Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 4.57B, an increase of 164.43%. That is a compound annual growth rate of 18.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.57B | -15.96% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 6.18B |
| Medigen Biotechnology | 5.20B |
| OBI Pharma | 4.69B |
| Mycenax Biotech | 4.69B |
| Sinew Pharma | 4.28B |
| BRIM Biotechnology | 4.12B |
| Pharmosa Biopharm | 4.05B |
| Formosa Pharmaceuticals | 3.87B |